Rheum fifth yr Flashcards
What is polymyalgia rheumatica?
an inflammatory condition that causes pain and stiffness in the shoulders, pelvic girdle and neck
strong association with GCA
Demographics of PMR?
> 50
F>M
Caucasians
Features of PMR?
core features, present for at least 2 weeks:
Bilateral shoulder pain that may radiate to the elbow
Bilateral pelvic girdle pain
Worse with movement
Interferes with sleep
Stiffness for at least 45 minutes in the morning
Rapid onset
Other features:
Systemic symptoms such as weight loss, fatigue, low grade fever and low mood
Upper arm tenderness
Carpel tunnel syndrome
Pitting oedema
Ix of PMR?
Diagnosis is mainly based on the clinical presentation and the response to steroids
Need to exclude other conditions:
Full blood count
Urea and electrolytes
Liver function tests
Calcium can be raised in hyperparathyroidism or cancer or low in osteomalacia
Serum protein electrophoresis for myeloma and other protein disorders
Thyroid stimulating hormone for thyroid function
Creatine kinase for myositis
Rheumatoid factor for rheumatoid arthritis
Urine dipstick
Additional investigations to consider:
Anti-nuclear antibodies (ANA) for systemic lupus erythematosus
Anti-cyclic citrullinated peptide (anti-CCP) for rheumatoid arthritis
Urine Bence Jones protein for myeloma
Chest xray for lung and mediastinal abnormalities
EMG normal
Inflammatory markers (ESR, plasma viscosity and CRP) are usually raised however normal inflammatory markers do not exclude PMR
Differentials of PMR?
Osteoarthritis
Rheumatoid arhtirits
Systemic lupus erythematosus
Myositis (from conditions like polymyositis or medications like statins)
Cervical spondylosis
Adhesive capsulitis of both shoulders
Hyper or hypothyroidism
Osteomalacia
Fibromyalgia
Tx of PMR?
Steroid regime
Initially patients are started on 15mg of prednisolone per day.
Assess 1 week after starting steroids. If there is a poor response in symptoms it is probably not PMR and an alternative diagnosis needs to be considered. Stop the steroids.
Assess 3-4 weeks after starting steroids. You would expect a 70% improvement in symptoms and inflammatory markers to return to normal to make a working diagnosis of PMR.
If 3-4 weeks of steroids has given a good response then start a reducing regime with the aim of getting the patient off steroids:
15mg until symptoms are fully controlled then
12.5mg for 3 weeks then
10mg for 4-6 weeks then
Reduce by 1mg every 4-8 weeks
Additional measures for patients taking long term steroids?
Don’t STOP
DON’T – Make them aware that they will become steroid dependent after 3 weeks of treatment and should not stop taking the steroids due to the risk of adrenal crisis if steroids are abruptly withdrawn
S – Sick Day Rules: Discuss increasing the steroid dose if they become unwell (“sick day rules”)
T – Treatment Card: Provide a steroid treatment card to alert others that they are steroid dependent in case they become unresponsive
O – Osteoporosis prevention: Consider osteoporosis prophylaxis whilst on steroids with bisphosphonates and calcium and vitamin D supplements
P – Proton pump inhibitor: Consider gastric protection with a proton pump inhibitor (e.g. omeprazole)
What is SLE?
an inflammatory autoimmune connective tissue disease. It is “systemic” because it affects multiple organs and systems and “erythematosus” refers to the typical red malar rash that occurs across the face. It presents with varying and non-specific symptoms
often takes a relapsing-remitting course, with flares and periods where symptoms are improved. The result of chronic inflammation means patients with lupus often have shortened life expectancy. Cardiovascular disease and infection are leading causes of death.
Demographics of SLE?
more common in women and Asians + Afro-Caribbean, and usually presents in young to middle aged adults (20-40) but can present later in life.
Pathophysiology of SLE?
ANA
antibodies to proteins within the persons own cell nucleus. This causes the immune system to target theses proteins - causing inflammatory response
Type 3 hypersensitivity reaction - thought to be caused by immune system dysregulation leading to immune complex formation
Associated with HLA B8, DR2, DR3
Presentation of SLE?
Fatigue
Weight loss
Arthralgia (joint pain) and non-erosive arthritis
Myalgia (muscle pain)
Fever
Photosensitive malar rash. This is a “butterfly” shaped rash across the nose and cheek bones that gets worse with sunlight.
Lymphadenopathy and splenomegaly
Shortness of breath
Pleuritic chest pain
Mouth ulcers
Hair loss
Raynaud’s phenomenon
Ix of SLE?
Autoantibodies:
ANA - non specific
anti-dsDNA - specific to SLE
Full blood count (normocytic anaemia of chronic disease)
C3 and C4 levels (decreased in active disease)
CRP and ESR (raised with active inflammation)
Immunoglobulins (raised due to activation of B cells with inflammation)
Urinalysis and urine protein:creatinine ratio for proteinuria in lupus nephritis
Renal biopsy can be used to investigate for lupus nephritis
Diagnosis of SLE?
SLICC Criteria or the ACR Criteria
involves confirming the presence of antinuclear antibodies and establishing a certain number of clinical features suggestive of SLE
Complications of SLE?
Cardiovascular disease - HTN and CAD
Infection - as part of disease but also secondary to immunosuppressants
Anaemia of chronic disease - normocytic anaemia, due to bone marrow inflammation, can also get leucopenia, neutropenia, thrombocytopenia
Pericarditis
Pleuritis
Interstitial lung disease - leads to pulmonary fibrosis
Lupus nephritis - ssessed urine protein:creatinine ratio and renal biopsy. The renal biopsy is often repeated to assess response to treatment. Can lead to ESRF
Neuropsychiatric SLE - optic neuritis (inflammation of the optic nerve), transverse myelitis (inflammation of the spinal cord) or psychosis.
Recurrent miscarriage, intrauterine growth restriction, pre-eclampsia and pre-term labour.
VTE - antiphospholipid syndrome occurring secondary to SLE
Treatment of SLE?
anti-inflammatory and immunosuppression to reduce Sx and complications
First line treatments are:
NSAIDs
Steroids (prednisolone)
Hydroxychloroquine (first line for mild SLE)
Suncream and sun avoidance for the photosensitive malar rash
Other commonly used immunosuppressants in resistant or more severe lupus: Methotrexate, Mycophenolate mofetil, Azathioprine, Tacrolimus, Leflunomide, Ciclosporin
Biological therapies: Rituximab (MAB target CD20 on B cells), Belimumab (MAB target B-cell activating factor)
Drug-induced lupus features?
arthralgia
myalgia
skin (e.g. malar rash) and pulmonary involvement (e.g. pleurisy) are common
ANA positive in 100%, dsDNA negative
anti-histone antibodies are found in 80-90%
anti-Ro, anti-Smith positive in around 5%
renal and nervous system involvement being unusual
Causes of drug-induced lupus?
Most common causes
procainamide
hydralazine
Less common causes
isoniazid
minocycline
phenytoin
What is polymyositis?
inflammatory disorder causing symmetrical, proximal muscle weakness. thought to be a T-cell mediated cytotoxic process directed against muscle fibres. Associated with malignancy
Affects middle-aged, F:M 3:1
Features of polymyositis?
Proximal muscle weakness +/- tenderness
Raynaud’s
Respiratory muscle weakness
Interstitial lung disease - fibrosis alveoli, organising pneumonia - indicates poor prognosis
Dysphagia, dysphonia
Investigations and management for polymyositis?
Elevated CK - usually >1000
Other muscle enzymes (LDH, aldolase, AST and ALT)
EMG
Muscle biopsy
Anti-synthetase antibodies - anti-Jo-1
Tx - high-dose corticosteroids, azathioprine as steroid-sparing agent, IV immunoglobulins, biologics (infliximab/etanercept)
PT/OT to help muscle strength and function
What is dermatomyositis?
an inflammatory disorder causing symmetrical, proximal muscle weakness and characteristic skin lesions
can be idiopathic, associated with CTD or underlying malignancy (ovarian, breast, lung)
Features of dermatomyositis?
photosensitive
macular rash over back and shoulder
heliotrope rash in the periorbital region
Gottron’s papules - roughened red papules over extensor surfaces of fingers
‘mechanic’s hands’: extremely dry and scaly hands with linear ‘cracks’ on the palmar and lateral aspects of the fingers
nail fold capillary dilatation
proximal muscle weakness +/- tenderness
Raynaud’s
respiratory muscle weakness
interstitial lung disease: e.g. Fibrosing alveolitis or organising pneumonia
dysphagia, dysphonia
Ix of dermatomyositis?
CK - usually >1000
Majority are ANA positive
Antibodies to aminoacyl-tRNA synthesase - anti-Jo-1, SRP, anti-Mi-2 antibodies
What is fibromyalgia?
syndrome characterised by widespread pain throughout the body with tender points at specific anatomical sites. The cause of fibromyalgia is unknown.
Women 5 times more affected
30-50 yrs old
Features of fibromyalgia
chronic pain: at multiple site, sometimes ‘pain all over’
lethargy
cognitive impairment: ‘fibro fog’
sleep disturbance, headaches, dizziness are common
Diagnosis and treatment of fibromyalgia?
Diagnosis is clinical and sometimes refers to the American College of Rheumatology
classification criteria which lists 9 pairs of tender points on the body. If a patient is tender in at least 11 of these 18 points it makes a diagnosis of fibromyalgia more likely
Management tailored to individual patient. Psychosocial and MDT approach.
Explanation
Aerobic exercise
CBT
Medication - pregabalin, duloxetine, amitriptyline
What is gout + features of gout?
type of crystal arthropathy and inflammatory arthritis. associated with chronically high blood uric acid levels. Urate crystals are deposited in the joint causing it to become hot, swollen and painful. Gout flares
Gouty tophi are subcutaneous deposits of uric acid typically affecting the small joints and connective tissues of the hands, elbows and ears. The DIP joints are most affected in the hands.
typically presents with a single acute hot, swollen and painful joint. Typical joints - metatarsophalangeal, wrists, carpometacarpal - also knee and ankle
Risk factors for gout?
Male
Obesity
High purine diet (e.g. meat and seafood)
Alcohol
Diuretics
Existing cardiovascular or kidney disease
Family history
increased production of uric acid - myeloproliferative, cytotoxic drugs, severe psoriasis
Lesch-Nyhan syndrome
Diagnosis of gout?
diagnosed clinically or by aspiration of fluid from the joint. Excluding septic arthritis is essential as this is a potential joint and life-threatening diagnosis.
uric acid - checked once acute episode settled down (2wks later)
Aspirated fluid - no bacterial growth, needle shaped, negatively birefringement of polarised light, monosodium urate crystals
X-ray - joint space maintained, lytic lesions in bone, punched out erosions with sclerotic borders and overhanging edges
Management of gout?
Acute:
NSAIDs, colchicine, steroids
colchicine - SE diarrhoea
Prophylaxis:
Allopurinol (xanthine oxidase inhibitor) - reduces uric acid levels
Lifestyle changes
What is pseudogout?
form of microcrystal synovitis caused by the deposition of calcium pyrophosphate dihydrate crystals in the synovium
Cause hot, swollen, stiff, painful knee - or shoulder, wrist, hip
Associated with increasing age. If younger (<60) then usually have underlying risk factor (haemochromatosis, hyperparathyroidism, low Mg, low phosphate, acromegaly, Wilsons)
Ix of pseudogout?
joint aspiration: weakly-positively birefringent rhomboid-shaped crystals
x-ray: chondrocalcinosis
in the knee this can be seen as linear calcifications of the meniscus and articular cartilage
Management of pseudogout?
aspiration of joint fluid, to exclude septic arthritis
NSAIDs or intra-articular, intra-muscular or oral steroids as for gout
Joint washout in severe cases